Endometrial Carcinoma Clinical Trials in Beijing, Beijing Municipality
5 recruitingBeijing, Beijing Municipality, China
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Study of GV20-0251 in Participants With Solid Tumor Malignancies
MelanomaNon-small Cell Lung CancerSolid Tumor Cancer+6 more
GV20 Therapeutics350 enrolled3 locationsNCT07070518
Recruiting
Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer
Atypical Endometrial HyperplasiaEndometrial Carcinoma Stage I
Peking University People's Hospital244 enrolled1 locationNCT05647109
Recruiting
Phase 2
Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
Peking University People's Hospital38 enrolled1 locationNCT06102863
Recruiting
Phase 2
Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Atypical Endometrial HyperplasiaEndometrial Carcinoma Stage I
Peking University People's Hospital82 enrolled1 locationNCT05675787
Recruiting
Phase 2
Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer
Endometrial CarcinomaTP53 MutationRecurrent or Metastatic
Cancer Institute and Hospital, Chinese Academy of Medical Sciences117 enrolled1 locationNCT06413992